Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.79 USD
Change Today +0.04 / 1.45%
Volume 79.3K
TRXC On Other Exchanges
As of 5:15 PM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

transenterix inc (TRXC) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/1/15 - $4.87
52 Week Low
12/15/14 - $1.40
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TRANSENTERIX INC (TRXC)

Related News

No related news articles were found.

transenterix inc (TRXC) Related Businessweek News

No Related Businessweek News Found

transenterix inc (TRXC) Details

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company develops SurgiBot System, a single-incision, patient-side robotic-assisted surgery system. The SurgiBot System comprises of SurgiBot Base, a reusable robotic base that provides the platform of the system; the EndoDrive, a single port, surgical access device for abdominal surgery; and the Positioning Arm, a reusable arm that supports and repositions the SurgiBot Base at the operating table. The company also develops and manufactures flexible and rigid laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, flexible energy device, and suction and irrigation instruments. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

98 Employees
Last Reported Date: 02/20/15

transenterix inc (TRXC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $400.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $282.8K
Compensation as of Fiscal Year 2014.

transenterix inc (TRXC) Key Developments

TransEnterix, Inc. Announces Amendment to Amended and Restated Loan and Security Agreement

TransEnterix, Inc. and certain of its subsidiaries are parties to that certain Amended and Restated Loan and Security Agreement, dated September 26, 2014, as amended in August 2015 and September 2015, with the lenders party thereto and Oxford Finance LLC, as collateral agent for the Lenders. On November 13, 2015, the company and such subsidiaries entered into the Third Amendment to the Loan Agreement pursuant to which the Lenders and the Collateral Agent agreed to increase the maximum designated amount that the company is permitted to invest in its Italian subsidiary, TransEnterix Italia S.r.l., subject to a limitation on the aggregate amount of cash that may be maintained at any one time by TransEnterix International, Inc. and TransEnterix Italia.

TransEnterix, Inc. Appoints Steven Boudrez as Vice President of Sales, Europe

TransEnterix, Inc. announced that Steven Boudrez, an experienced robotic surgery sales executive, has been appointed as Vice President of Sales, Europe. Mr. Boudrez will report directly to TransEnterix’s CEO, Todd M. Pope. Mr. Boudrez joins TransEnterix with nearly 20 years of experience in medical technology sales in the European market - of which 13 years were spent in leadership positions in the surgical robotics industry. He most recently served as Vice President of Sales, Europe at MedTech S.A.

TransEnterix, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 03:00 PM

TransEnterix, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 03:00 PM. Venue: The New York Palace Hotel, Hubbard Room, New York, New York, United States. Speakers: Joseph P. Slattery, Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Todd M. Pope, Chief Executive Officer, President and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRXC:US $2.79 USD +0.04

TRXC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Intuitive Surgical Inc $519.24 USD +1.37
Johnson & Johnson $102.37 USD +0.41
Medtronic PLC $76.46 USD -0.10
View Industry Companies

Industry Analysis


Industry Average

Valuation TRXC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,791.5x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,543.6x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TRANSENTERIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at